Passage Bio Debt To Equity vs. Market Capitalization
| PASG Stock | USD 0.62 0.11 21.57% |
Debt To Equity | First Reported 2010-12-31 | Previous Quarter 0.03031011 | Current Value 0.0186 | Quarterly Volatility 0.00363378 |
For Passage Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Passage Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Passage Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Passage Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Passage Bio over time as well as its relative position and ranking within its peers.
Passage |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Passage Bio. If investors know Passage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Passage Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.17) | Return On Assets (0.34) | Return On Equity (0.64) |
The market value of Passage Bio is measured differently than its book value, which is the value of Passage that is recorded on the company's balance sheet. Investors also form their own opinion of Passage Bio's value that differs from its market value or its book value, called intrinsic value, which is Passage Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Passage Bio's market value can be influenced by many factors that don't directly affect Passage Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Passage Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Passage Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Passage Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Passage Bio Market Capitalization vs. Debt To Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Passage Bio's current stock value. Our valuation model uses many indicators to compare Passage Bio value to that of its competitors to determine the firm's financial worth. Passage Bio is regarded fourth in debt to equity category among its peers. It is regarded fifth in market capitalization category among its peers creating about 348,704,473 of Market Capitalization per Debt To Equity. At this time, Passage Bio's Debt To Equity is most likely to increase slightly in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Passage Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Passage Market Capitalization vs. Debt To Equity
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Passage Bio |
| = | 0.11 % |
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Passage Bio |
| = | 38.36 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
Passage Market Capitalization vs Competition
Passage Bio is regarded fifth in market capitalization category among its peers. Market capitalization of Health Care industry is at this time estimated at about 10.59 Billion. Passage Bio adds roughly 38.36 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Passage Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Passage Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Passage Bio will eventually generate negative long term returns. The profitability progress is the general direction of Passage Bio's change in net profit over the period of time. It can combine multiple indicators of Passage Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -43 K | -45.1 K | |
| Net Interest Income | 2.6 M | 2.7 M | |
| Interest Income | 2.6 M | 2.7 M | |
| Operating Income | -108.4 M | -113.8 M | |
| Net Loss | -112.4 M | -118 M | |
| Income Before Tax | -102.1 M | -107.2 M | |
| Total Other Income Expense Net | 6.3 M | 6.6 M | |
| Net Loss | -122.5 M | -128.6 M | |
| Net Loss | -102.1 M | -107.2 M | |
| Income Tax Expense | 5.4 M | 3.7 M | |
| Non Operating Income Net Other | 2 M | 2.1 M | |
| Change To Netincome | 21.8 M | 17.7 M | |
| Net Loss | (1.86) | (1.96) | |
| Income Quality | 0.77 | 0.98 | |
| Net Income Per E B T | 1.16 | 1.17 |
Passage Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Passage Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Passage Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Passage Bio's important profitability drivers and their relationship over time.
Use Passage Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Passage Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Passage Bio will appreciate offsetting losses from the drop in the long position's value.Passage Bio Pair Trading
Passage Bio Pair Trading Analysis
The ability to find closely correlated positions to Passage Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Passage Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Passage Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Passage Bio to buy it.
The correlation of Passage Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Passage Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Passage Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Passage Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Passage Bio position
In addition to having Passage Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Driverless Cars Thematic Idea Now
Driverless Cars
It encompasses large technology companies, automotive makers, security firms, and thematic ETFs across multiple industries. These entities are directly or indirectly involved in shaping the development and marketing of self-driving vehicles. The Driverless Cars theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Driverless Cars Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. For more detail on how to invest in Passage Stock please use our How to Invest in Passage Bio guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
To fully project Passage Bio's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Passage Bio at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Passage Bio's income statement, its balance sheet, and the statement of cash flows.